Beam Therapeutics Inc.
BEAMFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
64
Cost of Revenue
368
Gross Profit
-304
Gross Margin
-478.7%
Operating Income
-416
Operating Margin
-654.3%
Net Income
-377
Net Margin
-593.1%
EPS (Basic)
$-4.58
EPS (Diluted)
$-4.58
EBITDA
-394
EBITDA Margin
-619.7%
2023
12/31/2023
Revenue
378
Cost of Revenue
0
Gross Profit
378
Gross Margin
100.0%
Operating Income
-176
Operating Margin
-46.7%
Net Income
-133
Net Margin
-35.1%
EPS (Basic)
$-1.72
EPS (Diluted)
$-1.72
EBITDA
-147
EBITDA Margin
-38.9%
2022
12/31/2022
Revenue
61
Cost of Revenue
312
Gross Profit
-251
Gross Margin
-411.5%
Operating Income
-338
Operating Margin
-555.6%
Net Income
-289
Net Margin
-474.5%
EPS (Basic)
$-4.13
EPS (Diluted)
$-4.13
EBITDA
-324
EBITDA Margin
-532.4%
2021
12/31/2021
Revenue
52
Cost of Revenue
232
Gross Profit
-180
Gross Margin
-347.8%
Operating Income
-392
Operating Margin
-757.0%
Net Income
-371
Net Margin
-714.9%
EPS (Basic)
$-5.77
EPS (Diluted)
$-5.77
EBITDA
-230
EBITDA Margin
-443.8%
2020
12/31/2020
Revenue
0
Cost of Revenue
103
Gross Profit
-103
Gross Margin
-429812.5%
Operating Income
-133
Operating Margin
-553166.7%
Net Income
-195
Net Margin
-810800.0%
EPS (Basic)
$-5.49
EPS (Diluted)
$-5.49
EBITDA
-128
EBITDA Margin
-533437.5%